[go: up one dir, main page]

HK1247925A1 - 用於治療和預防病毒感染的新的磺亞氨酰基嘌呤酮化合物和衍生物 - Google Patents

用於治療和預防病毒感染的新的磺亞氨酰基嘌呤酮化合物和衍生物

Info

Publication number
HK1247925A1
HK1247925A1 HK18107428.7A HK18107428A HK1247925A1 HK 1247925 A1 HK1247925 A1 HK 1247925A1 HK 18107428 A HK18107428 A HK 18107428A HK 1247925 A1 HK1247925 A1 HK 1247925A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
derivatives
novel
treatment
virus infection
Prior art date
Application number
HK18107428.7A
Other languages
English (en)
Inventor
Chungen Liang
Kun Miao
Jianping Wang
Hongying Yun
Xiufang Zheng
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1247925A1 publication Critical patent/HK1247925A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18107428.7A 2015-05-08 2018-06-07 用於治療和預防病毒感染的新的磺亞氨酰基嘌呤酮化合物和衍生物 HK1247925A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2015078507 2015-05-08
CN2016078785 2016-04-08
PCT/EP2016/059961 WO2016180695A1 (en) 2015-05-08 2016-05-04 Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection

Publications (1)

Publication Number Publication Date
HK1247925A1 true HK1247925A1 (zh) 2018-10-05

Family

ID=55910966

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107428.7A HK1247925A1 (zh) 2015-05-08 2018-06-07 用於治療和預防病毒感染的新的磺亞氨酰基嘌呤酮化合物和衍生物

Country Status (33)

Country Link
US (3) US9708325B2 (zh)
EP (1) EP3294740B1 (zh)
JP (1) JP6738352B2 (zh)
KR (1) KR102690131B1 (zh)
CN (1) CN107580596B (zh)
AR (1) AR104528A1 (zh)
AU (3) AU2016260683B2 (zh)
BR (1) BR112017023959B1 (zh)
CA (1) CA2982704C (zh)
CL (1) CL2017002745A1 (zh)
CO (1) CO2017009994A2 (zh)
CR (1) CR20170496A (zh)
DK (1) DK3294740T3 (zh)
ES (1) ES2753777T3 (zh)
HK (1) HK1247925A1 (zh)
HR (1) HRP20191942T1 (zh)
HU (1) HUE045906T2 (zh)
IL (2) IL254947B (zh)
LT (1) LT3294740T (zh)
MX (2) MX376761B (zh)
MY (1) MY182353A (zh)
NZ (2) NZ775222A (zh)
PE (1) PE20171620A1 (zh)
PH (1) PH12017502009A1 (zh)
PL (1) PL3294740T3 (zh)
PT (1) PT3294740T (zh)
RS (1) RS59435B1 (zh)
RU (1) RU2745269C2 (zh)
SG (1) SG10202108841YA (zh)
SI (1) SI3294740T1 (zh)
TW (2) TWI768467B (zh)
UA (1) UA120450C2 (zh)
WO (1) WO2016180695A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ775222A (en) 2015-05-08 2024-09-27 Hoffmann La Roche Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
MX2019002129A (es) * 2016-08-29 2019-06-20 Hoffmann La Roche Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica.
CA3034185A1 (en) * 2016-09-13 2018-03-22 F. Hoffmann-La Roche Ag Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor
JP7328977B2 (ja) 2018-02-12 2023-08-17 エフ． ホフマン－ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
BR112020016509A2 (pt) * 2018-02-28 2020-12-15 F. Hoffmann-La Roche Ag Composto, composto para uso no tratamento ou profilaxia do câncer de fígado, composição farmacêutica ou medicamento, uso e método para o tratamento ou profilaxia do câncer de fígado
CN111072667A (zh) * 2018-10-22 2020-04-28 罗欣药业(上海)有限公司 五元或六元杂环并嘧啶类化合物及其用途
US20220226488A1 (en) * 2019-02-12 2022-07-21 Ambrx, Inc. Compositions containing, methods and uses of antibody-tlr agonist conjugates
CN114450280B (zh) 2019-09-20 2025-02-25 先正达农作物保护股份公司 具有含硫和亚砜亚胺取代基的杀有害生物活性杂环衍生物
CN119604517A (zh) 2022-07-14 2025-03-11 豪夫迈·罗氏有限公司 用于治疗癌症的磷酰基嘌呤酮化合物
CN118724963A (zh) * 2023-03-30 2024-10-01 浙江养生堂天然药物研究所有限公司 含磷或含硫的大环化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4189048B2 (ja) 1997-12-26 2008-12-03 大日本住友製薬株式会社 複素環化合物
EA200702235A1 (ru) 2005-05-04 2008-04-28 Пфайзер Лимитед Производные 2-амидо-6-амино-8-оксопурина в качестве модуляторов toll-подобных рецепторов для лечения рака и вирусных инфекций, таких как гепатит с
CN101239980B (zh) 2008-02-18 2011-06-22 靳广毅 免疫受体调节剂偶联体前体和偶联体及其应用
AP2011005745A0 (en) * 2008-12-09 2011-06-30 Gilead Sciences Inc Modulators of toll-like receptors.
WO2011079016A1 (en) 2009-12-22 2011-06-30 Gilead Sciences, Inc. Methods of treating hbv and hcv infection
TW201636330A (zh) * 2011-05-24 2016-10-16 拜耳知識產權公司 含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
AU2012334127B2 (en) 2011-11-09 2017-05-18 Janssen Sciences Ireland Uc Purine derivatives for the treatment of viral infections
JP6336036B2 (ja) 2013-03-29 2018-06-06 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染治療のための大環状デアザプリノン
PT3190113T (pt) 2014-08-15 2021-06-17 Chai Tai Tianqing Pharmaceutical Group Co Ltd Compostos pirrolopirimidina utilizados como agonistas de tlr7
NZ775222A (en) * 2015-05-08 2024-09-27 Hoffmann La Roche Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
MX2019002129A (es) * 2016-08-29 2019-06-20 Hoffmann La Roche Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica.

Also Published As

Publication number Publication date
AU2020256348B2 (en) 2022-06-16
US20160326177A1 (en) 2016-11-10
CL2017002745A1 (es) 2018-05-18
ES2753777T3 (es) 2020-04-14
TW201716410A (zh) 2017-05-16
BR112017023959B1 (pt) 2023-05-02
SI3294740T1 (sl) 2019-12-31
UA120450C2 (uk) 2019-12-10
AU2022204666A1 (en) 2022-07-21
CR20170496A (es) 2017-12-05
CN107580596A (zh) 2018-01-12
IL280769B1 (en) 2023-03-01
NZ775222A (en) 2024-09-27
CA2982704A1 (en) 2016-11-17
HUE045906T2 (hu) 2020-01-28
IL254947A0 (en) 2017-12-31
RU2017142577A (ru) 2019-06-10
PT3294740T (pt) 2019-10-29
US20170275286A1 (en) 2017-09-28
JP2018515509A (ja) 2018-06-14
SG10202108841YA (en) 2021-09-29
MX2017014033A (es) 2018-03-01
JP6738352B2 (ja) 2020-08-12
LT3294740T (lt) 2019-11-25
US20200109144A1 (en) 2020-04-09
US11242345B2 (en) 2022-02-08
RS59435B1 (sr) 2019-11-29
RU2745269C2 (ru) 2021-03-22
TW202108584A (zh) 2021-03-01
IL280769A (en) 2021-04-29
TWI706954B (zh) 2020-10-11
IL280769B2 (en) 2023-07-01
US10399983B2 (en) 2019-09-03
HRP20191942T1 (hr) 2020-01-10
KR102690131B1 (ko) 2024-07-31
NZ735648A (en) 2023-06-30
PH12017502009A1 (en) 2018-03-26
EP3294740A1 (en) 2018-03-21
AU2016260683A1 (en) 2017-10-12
TWI768467B (zh) 2022-06-21
CO2017009994A2 (es) 2018-02-20
US9708325B2 (en) 2017-07-18
IL254947B (en) 2021-02-28
CA2982704C (en) 2023-10-24
PL3294740T3 (pl) 2020-03-31
MY182353A (en) 2021-01-20
PE20171620A1 (es) 2017-11-02
WO2016180695A1 (en) 2016-11-17
AU2016260683B2 (en) 2020-10-29
EP3294740B1 (en) 2019-09-04
KR20180003612A (ko) 2018-01-09
RU2017142577A3 (zh) 2019-10-31
MX376761B (es) 2025-03-07
AR104528A1 (es) 2017-07-26
MX2020010949A (es) 2022-06-16
BR112017023959A2 (pt) 2018-07-17
CN107580596B (zh) 2020-07-14
AU2020256348A1 (en) 2020-11-12
DK3294740T3 (da) 2019-11-04

Similar Documents

Publication Publication Date Title
HK1248711A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
HRP20190352T1 (hr) Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b
IL284255A (en) 7-substituted sulfonimidylpurinone compounds for the treatment and prevention of viral infection
HK1251220A1 (zh) 用於治療和預防乙型肝炎病毒感染的新的四環4-氧代-吡啶-3-甲酸衍生物
HK1251221A1 (zh) 用於治療和預防乙型肝炎病毒感染的新的三環4-吡啶酮-3-甲酸衍生物
HK1223931A1 (zh) 用於治療和預防乙型肝炎病毒感染的新型二氫喹嗪酮類化合物
IL280769A (en) New sulfonimidylpurinone compounds and their history for the treatment and prevention of virus infection
HK1251554A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
HK1250480A1 (zh) 用於治療hbv感染的組合物和方法
PL3261642T3 (pl) Pochodne chinoliny do zastosowania w leczeniu lub zapobieganiu zakażeniom wirusowym
HK1252343A1 (zh) 用於治療病毒感染的組合物和方法
HK1250709A1 (zh) 用於治療和預防病毒感染的新的氧硫雜環戊烷甲酸及其衍生物
ZA201900770B (en) 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
LT3504210T (lt) Nauji 7 padėtyje pakeisti sulfonimidoilpurinono junginiai, skirti viruso sukeliamos infekcijos gydymui ir profilaktikai
ZA201604784B (en) Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection